Lexicon Pharmaceuticals LXRX Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating income?
- Lexicon Pharmaceuticals (LXRX) reported operating income of -$996K in Q1 2026.
- How has Lexicon Pharmaceuticals's operating income changed year-over-year?
- Lexicon Pharmaceuticals's operating income increased by 96.1% year-over-year, from -$25.68M to -$996K.
- What is the long-term trend for Lexicon Pharmaceuticals's operating income?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's operating income has grown at a -13.4% compound annual growth rate (CAGR), from -$87.09M to -$48.91M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.